Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)

NCT03493165 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

OTHER

Sponsor class

Conditions

Uterine Sarcoma

Interventions

DRUG: Everolimus

Sponsor

The University of Texas Health Science Center at San Antonio